Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Molecular Psychiatry|July 28, 2022
Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pathologyYunseon Yang, Min-Jong Seok, Ye Eun Kim, et al.
Cell Reports|August 1, 2019
Activation of Astrocytic μ-Opioid Receptor Causes Conditioned Place PreferenceMin-Ho Nam, Kyung-Seok Han, Jaekwang Lee, et al.
Clinical Nuclear Medicine|July 22, 2022
11 C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma ClassificationDongwoo Kim, Joong Hyun Chun, Ju Hyeon Yi, et al.
Nature Communications|March 6, 2024
Fully bioresorbable hybrid opto-electronic neural implant system for simultaneous electrophysiological recording and optogenetic stimulationMyeongki Cho, Jeong-Kyu Han, Jungmin Suh, et al.
Cell Reports|July 9, 2020
Excessive Astrocytic GABA Causes Cortical Hypometabolism and Impedes Functional Recovery after Subcortical StrokeMin-Ho Nam, Jongwook Cho, Dae-Hyuk Kwon, et al.
Experimental & Molecular Medicine|April 24, 2026
Curing the brain: in search for new astrocyte-specific therapiesAlexei Verkhratsky, C Justin Lee, Heejung Chun, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 6, 2021
KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's DiseaseMin-Ho Nam, Jong-Hyun Park, Hyo Jung Song, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 9, 2024
Central Role of Hypothalamic Circuits for Acupuncture's Anti-Parkinsonian EffectsJu-Young Oh, Hyowon Lee, Sun-Young Jang, et al.
Signal Transduction and Targeted Therapy|September 10, 2025
Astrocytic monoamine oxidase B (MAOB)-gamma-aminobutyric acid (GABA) axis as a molecular brake on repair following spinal cord injuryHye Yeong Lee, Jung Moo Lee, Hye-Lan Lee, et al.
Science Advances|March 26, 2019
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's diseaseJong-Hyun Park, Yeon Ha Ju, Ji Won Choi, et al.
Pageof 7